COVID–19 Medical Production Act
- Last Action
- 3/9/2021
Actions
- 2021-03-09Referred to the House Committee on Financial Services.
- 2021-03-09Introduced in House
- 2021-03-09Introduced in House
CRS Summary
As of 2021-03-09 (00)
COVID-19 Medical Production Act
This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense.
This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.
Cosponsors (1)
- MAXINE WATERS (D-CA)
Subjects
- Appropriations
- Cardiovascular and respiratory health
- Emergency medical services and trauma care
- Health technology, devices, supplies
- Immunology and vaccination
- Infectious and parasitic diseases
- Manufacturing
- Medical tests and diagnostic methods
- Military procurement, research, weapons development
- Public contracts and procurement
- Worker safety and health
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.